Senile cataract is caused by the nuclear matter of the elderly human
lens hardening and taking on a yellowish/brown color. Once this occurs
there is obvious vision impairment and deterioration. The term
'senile' is used because this disease primarily affects people aged 50 and
over. When not treated, cataracts are a common cause of blindness in
elderly people. The most common treatment is surgery in which the
cloudy lens is removed and replaced with an artificial lens called an
Senile cataract surgery is the most commonly performed surgical
operation in the world today. There are approximately 1.35 million eye operations each
year in the USA.
Human trials show that
the ingredients in Can-C eye-drops, applied
for 6-months (twice daily into the eye), in patients all suffering from
senile cataract, had the following results:
1. 88.9% had an improvement of glare sensitivity.
2. 41.5% had an improvement in the transmissivity of the lens.
3. 90% had an improvement in visual acuity.
Another study also evaluated patients between the ages of 48 and 60,
who had various degrees of eyesight impairment, but who did not have the
symptoms of cataract. After a course of treatment ranging from 2 to 6
months, the conclusion was that the ingredients contained in Can-C eye-drops alleviated eye-tiredness and
continued to improve eyesight (i.e. there was more clear vision). The
subjects reported that the treatment "brightened" and
"relaxed" their eyes.
How does N-acetylcarnosine work
in the eye: Cataracts are caused by the hardening and discoloration of the
lens due to lifelong cross-linking (glycosylation) of the lens proteins
with ascorbate. This persists in the aqueous humor at high concentrations,
due to the low availability of natural defenses in the form of
anti-oxidants (which decline with advancing age). N-acetylcarnosine
delivers L-carnosine into the aqueous humor of the eye (the fluid area
surrounding the lens) where it acts as a natural and comprehensive
anti-oxidant, protecting structural lens proteins from the free-radical
induced oxidation process.
A cataract develops when antioxidant defense is exhausted, leading to the cross-linking of the
lens crystallins and producing a clouded lens and impaired eyesight.
The clinic trials show that the regular use of a 1% N-acetylcarnosine
eye-drop, delivers a high-dose of carnosine capable of
reversing the lens cross-linking, and aids in the reduction and possible eradication of
here for a Pub Med article on effectiveness of N-acetylcarnosine for the treatment of
Dr. Babizhayev who headed the Russian research team (Innovative Vision
Products) that developed this innovative treatment, has stated that the
maximum obtainable results are usually achieved in a 3 to 6 month period,
however there are often noticeable benefits within only 1 month.
Marios Kyriazis, M.D., has written a booklet on the subject entitled
“The Cataract Cure.” In it he states that the research highlights that
quality and formula are essential to both efficacy and long-term safety.
To ensure that you are purchasing an officially approved and tested
product, the packaging should clearly state that it is approved by
Innovative Vision Products (IVP).
- Two drops into the affected eye twice
daily is the ideal. There should be no added benefit in exceeding this
amount. You may wish to continue occasional use of N-acetylcarnosine
eye-drops after the reduction/reversal of the cataract to prevent any
- As a preventative measure, two drops
into both eyes once a day may be used.
Information from Can-C ® Eye Drops
CAN-C 2 x 5ml VIALS
Active ingredients: Glycerine (lubricant) 1%, Carboxymethylcellulose
sodium (lubricant) 0.3%.
Inactive ingredients: Sterile Water (ophthalmic grade solution pH 6.3 to
Antioxidants: N-Acetyl-Carnosine (NAC)* 1%.
Buffers: Borate, Potassium Bicarbonate.
Preservative: Purified Benzyl Alcohol.
*Patented by Innovative Vision Products
1 or 2 drops in each eye 1-4
times a day or as directed by a physician. Please read the enclosed
product insert carefully. For the proper installation of drops, lean head
back and look up. Do not blink or reopen the eye for 60-seconds. Repeat
this procedure, if a second drop is used. Closing the eye allows each drop
to be absorbed into the eye tissue. Blinking, even one or two times, will
pump most of the solution out of the eye. If you have neck problems, lie
down or use a tilt-back chair.
Application: Lean your head
back and look up. Instill “one drop” then slowly and gently close the
eye. Do not blink or reopen for 60 seconds. Repeat this procedure, if a
second drop is used. This allows each drop to be absorbed into the eye
tissue. Blinking, even one or two times, will pump most of the solution
out of the eye. If you have neck problems, lie down or use a tilt-back
For temporary relief of
discomfort due to minor irritations to the eye or exposure to wind or sun.
For use as a lubricant and protectant against irritation or to relieve
dryness of the eye.
To avoid contamination, do not
touch the tip of container to any surface. Replace the cap immediately
after using. Open only one container of solution at a time. Do not allow
other people to use your container. Once open, discard container and any
contents after 30-days. Do not heat beyond room temperature, keep the
extra tubes in the box away from light, especially sunlight. Do not
freeze. Do not use if seal is broken or if solution changes color or
becomes cloudy. Not recommended for children under the age of 12 years. If
the eye tissue becomes more inflamed, red, irritated or uncomfortable
after using this product, immediately discontinue the use of product and
consult an eye-physician if necessary. Keep this and all drugs out of the
reach of children.
This product can be stored at normal room temperature, however to obtain
maximum shelf life of the ingredients, the product should be stored in the
refrigerator, but do not freeze. Do not use past expiry date.
This product is manufactured in accordance with the requirements as set
forth by the Food and Drug Administration monograph for ophthalmic
products. The statements contain herein have not been evaluated by the
Food and Drug Administration. This product is not intended to diagnose,
treat, cure or prevent any disease.